Comparison of pharmacokinetics and safety of voriconazole intravenous-to-oral switch in immunocompromised adolescents and healthy adults.

Driscoll TA, Frangoul H, Nemecek ER, Murphey DK, Yu LC, Blumer J, Krance RA, Baruch A, Liu P
Antimicrob Agents Chemother. 2011 55 (12): 5780-9

PMID: 21911570 · PMCID: PMC3232803 · DOI:10.1128/AAC.05010-11

MeSH Terms (22)

Administration, Oral Adolescent Adult Antifungal Agents Aryl Hydrocarbon Hydroxylases Child Cytochrome P-450 CYP2C19 Dose-Response Relationship, Drug Drug Administration Schedule Female Genotype Humans Immunocompromised Host Injections, Intravenous Liver Function Tests Male Middle Aged Pyrimidines Treatment Outcome Triazoles Voriconazole Young Adult

Connections (1)

This publication is referenced by other Labnodes entities: